BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 21971543)

  • 1. A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).
    Rabasseda X; Gómez-Zaera M
    Drugs Today (Barc); 2011 Sep; 47(9):693-737. PubMed ID: 21971543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology (ASCO) - 55th Annual Meeting (May 31-June 4, 2019 - Chicago, Illinois, USA).
    Kibble A; Kuenneman K; de Las Heras Prat P
    Drugs Today (Barc); 2019 Jun; 55(6):407-415. PubMed ID: 31250844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology 41st annual meeting.
    Dillman RO
    Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA).
    Rabasseda X; Gómez-Zaera M
    Drugs Today (Barc); 2010 Sep; 46(9):699-731. PubMed ID: 20967301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights from the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) (June 3-7, 2016 - Chicago, Illinois, USA).
    Kibble A; Al-Shamahi A; Kuennemann K; Marqués F; Tremosa L; Cole P
    Drugs Today (Barc); 2016 Jul; 52(7):407-23. PubMed ID: 27540600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Hsu C; Saif MW
    JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.
    Chen LF; Patel JD; Lukas RV
    Future Oncol; 2016 Nov; 12(22):2535-2538. PubMed ID: 27595336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 47th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL, USA, 3-7 June 2011: focus on Pediatric Oncology.
    Wilde MI
    Paediatr Drugs; 2011 Oct; 13(5):325-8. PubMed ID: 21888446
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merika E; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
    Fontanella C; Aprile G; Scartozzi M; Lederer B; Cascinu S; von Minckwitz G
    Future Oncol; 2014 Oct; 10(12):1901-6. PubMed ID: 25386808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Dimou AT; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 39th Annual Meeting of the American Society of Clinical Oncology: Chicago, Illinois, May 30 to June 3, 2003.
    Lee D; DeGrendele H
    Clin Lung Cancer; 2003 Jul; 5(1):13-7. PubMed ID: 14596697
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Alsamarai S; Libutti SK; Saif MW
    JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Li J; Ng J; Allendorf J; Saif MW
    JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Kim R; Chabot J; Saif MW
    JOP; 2011 Jul; 12(4):362-3. PubMed ID: 21737897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Chang BW; Siccion E; Saif MW
    JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
    Erlich R; Durrance A
    IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
    [No Abstract]   [Full Text] [Related]  

  • 20. American Society of Clinical Oncology--46th annual meeting.
    Al-Shamahi A; Murch L; Kirkham K
    IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.